HPGC Renmintongtai Pharmaceutical: Q3 2026 Earnings, Flat Stock, Awaiting Catalysts
HPGC Renmintongtai Pharma stays flat at CNY 8.93—steady distribution, Q3 earnings hint at future growth, investors watch for new approvals or deals.
3 minutes to read